Increased production of nitric oxide correlates with tumor growth in Algerian patients with nasopharyngeal carcinoma

被引:9
作者
Bourouba, Mehdi [1 ]
Boukercha, Aziza [1 ]
Zergoun, Ahmed-Amine [1 ]
Zebboudj, Abderezak [1 ]
Elhadjan, Mohamed [2 ]
Djenaoui, Djamel [2 ]
Asselah, Fatima [3 ]
Touil-Boukoffa, Chafia [1 ]
机构
[1] USTHB, Fac Biol Sci, Lab Cell & Mol Biol LBCM, Team Cytokines & Nitr Oxide synthases, Algiers, Algeria
[2] Mustapha Pacha Hosp, Fac Med, Otorhynolaryngol Dept, Algiers, Algeria
[3] Mustapha Pacha Hosp, Fac Med, Anatomopathol Dept, Algiers, Algeria
关键词
Nasopharyngeal carcinoma; UCNT; nitric oxide; biomarker; inflammation; carcinogenesis; ACTIVATED PROTEIN-KINASES; INFILTRATING LYMPHOCYTES; EPITHELIAL-CELLS; CANCER-RISK; DNA-DAMAGE; SYNTHASE; EXPRESSION; P53; INFLAMMATION; ASSOCIATION;
D O I
10.3109/1354750X.2012.706643
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 [微生物学]; 090105 [作物生产系统与生态工程];
摘要
Nasopharyngeal carcinoma (NPC) is thought to arise because of chronic inflammation. The correlation between nitric oxide (NO) production, a biomarker of inflammation and NPC development remains unexplored. To investigate this question, we performed a profile analysis on plasma collected from untreated, treated, remissive, cured and relapsing patients. Nitrites were measured to assess NO activity. We observed that increased nitrites concentrations in untreated and relapsing patients associated with tumor development. Moreover, nitrites levels were similar in remissive, cured and healthy individuals. Altogether, our results suggest that NO might be an interesting blood biomarker to monitor tumor growth in NPC patients.
引用
收藏
页码:618 / 624
页数:7
相关论文
共 49 条
[1]
The prognostic value of inducible nitric oxide synthase in local prostate cancer [J].
Aaltomaa, SH ;
Lipponen, PK ;
Viitanen, J ;
Kankkunen, JP ;
Ala-Opas, MY ;
Kosma, VM .
BJU INTERNATIONAL, 2000, 86 (03) :234-239
[2]
Effect of corticotherapy on interleukin-8 and -12 and nitric oxide production during Behcet and idiopathic uveitis [J].
Belguendouz, H. ;
Messaoudene, D. ;
Hartani, D. ;
Chachoua, L. ;
Ahmedi, M. L. ;
Lahmar-Belguendouz, K. ;
Lahlou-Boukoffa, O. ;
Touil-Boukoffa, C. .
JOURNAL FRANCAIS D OPHTALMOLOGIE, 2008, 31 (04) :387-395
[3]
Association of IL-12p40+1188 A/C polymorphism with nasopharyngeal cancer risk and tumor extension [J].
Ben Chaaben, A. ;
Busson, M. ;
Douik, H. ;
Boukouaci, W. ;
Mamoghli, T. ;
Chaouch, L. ;
Harzallah, L. ;
Dorra, S. ;
Fortier, C. ;
Ghanem, A. ;
Charron, D. ;
Krishnamoorthy, R. ;
Guemira, F. ;
Tamouza, R. .
TISSUE ANTIGENS, 2011, 78 (02) :148-151
[4]
Epidermal growth factor receptor (EGFR) abundance correlates with p53 and Bcl-2 accumulation and patient age in a small cohort of North African nasopharyngeal carcinoma patients [J].
Bourouba, Mehdi ;
Benyelles-Boufennara, Assia ;
Terki, Nadia ;
Baraka-Kerboua, Esma ;
Bouzid, Kamel ;
Touil-Boukoffa, Chafia .
EUROPEAN CYTOKINE NETWORK, 2011, 22 (01) :38-44
[5]
Chan ED, 1999, J IMMUNOL, V162, P415
[6]
Systematic evaluation of the mitogen-activated protein kinases in the induction of iNOS by tumor necrosis factor-alpha and interferon-gamma [J].
Chan, ED ;
Winston, BW ;
Uh, ST ;
Remigio, LK ;
Riches, DWH .
CHEST, 1999, 116 (01) :91S-92S
[7]
Macrophage Inflammatory Protein-3α Is a Novel Serum Marker for Nasopharyngeal Carcinoma Detection and Prediction of Treatment Outcomes [J].
Chang, Kai-Ping ;
Hao, Sheng-Po ;
Chang, Jui-Hung ;
Wu, Chih-Ching ;
Tsang, Ngan-Ming ;
Lee, Yun-Shien ;
Hsu, Chen-Lung ;
Ueng, Shir-Hwa ;
Liu, Shiau-Chin ;
Liu, Yu-Lun ;
Wei, Pei-Cih ;
Liang, Yin ;
Chang, Yu-Sun ;
Yu, Jau-Song .
CLINICAL CANCER RESEARCH, 2008, 14 (21) :6979-6987
[8]
A positive autoregulatory loop of LMP1 expression and STAT activation in epithelial cells latently infected with Epstein-Barr virus [J].
Chen, HL ;
Hutt-Fletcher, L ;
Cao, L ;
Hayward, SD .
JOURNAL OF VIROLOGY, 2003, 77 (07) :4139-4148
[9]
Identification of serum amyloid a protein as a potentially useful biomarker to monitor relapse of nasopharyngeal cancer by serum proteomic profiling [J].
Cho, WCS ;
Yip, TTC ;
Yip, C ;
Yip, V ;
Thulasiraman, V ;
Ngan, RKC ;
Yip, TT ;
Lau, WH ;
An, JSK ;
Law, SCK ;
Cheng, WW ;
Ma, VWS ;
Lim, CKP .
CLINICAL CANCER RESEARCH, 2004, 10 (01) :43-52
[10]
Dhar A, 2003, MOL CANCER THER, V2, P1285